4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biocon Limited (BIOCON) operates in the Biotechnology industry and is headquartered in Bengaluru, India with about 16,447 employees. Its market capitalization is roughly ₹627 billion. In the fiscal year ended 2026-03-31, BIOCON reported ₹167.8B in revenue and ₹3.9B in net income.
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹167.8B | ₹150.5B | ₹142.0B | ₹109.3B |
| Gross Profit | ₹110.9B | ₹98.5B | ₹92.9B | ₹72.7B |
| Operating Income (EBIT) | ₹17.2B | ₹16.3B | ₹14.3B | ₹16.3B |
| Net Income | ₹3.9B | ₹10.1B | ₹10.2B | ₹4.6B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | ₹42.9B | ₹44.8B | ₹41.7B | ₹42.6B | ₹39.1B |
| Gross Profit | ₹28.2B | ₹30.9B | ₹28.3B | ₹27.2B | ₹25.1B |
| Operating Income (EBIT) | ₹3.0B | ₹5.1B | ₹3.2B | ₹3.6B | ₹3.1B |
| Net Income | ₹1.4B | ₹1.3B | ₹1.4B | ₹845M | ₹314M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹908M) | (₹829M) | (₹2.0B) | (₹718M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹636.5B | ₹588.0B | ₹560.7B | ₹520.4B | — |
| Total Liabilities | ₹270.3B | ₹310.8B | ₹308.0B | ₹295.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIOCON viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms